563-06-003 ISMRM Abstract

Quantitative Sodium MRI for Pituitary Neuroendocrine Tumors: A Preliminary 3T Study

Primary: Neuro - Tumors

Secondary: Neuro - Neurofluids

563-06-003 · From Molecular Signatures to Surgical Guidance: Cutting-Edge MRI in Brain Tumor Care · Wednesday, 13 May, 4:55 PM–5:50 PM · Digital Posters Row D

Keywords: Non-Proton MRI Quantitative Sodium MRI

Accepted

Peng Liu¹, Naying He¹, Jinyuan Weng², Peng Wu ², Zhongping Zhang², Fuhua Yan^1,3

¹Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

²Clinical and Technical Support, Philips Healthcare (Beijing), Beijing, China

³Faculty of Medical Imaging Technology, College of Health Science and Technology, Shanghai Jiao Tong University School of Medicine, Shanghai, China

Presenting Author: Peng Wu

Synopsis

Motivation:

Goals:

Approach:

Results:

Full abstract & presentation

The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.

Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.

To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.

References

1. Zhang F, Zhang Q, Zhu J, et al. Integrated proteogenomic characterization across major histological types of pituitary neuroendocrine tumors. Cell Res. 2022, 32(12):1047-1067.

2. Madelin Guillaume. Sodium Magnetic Resonance Imaging: Biomedical Applications. https://doi.org/10.48550/arXiv.1212.4400 [doi]

3. Keith R. Thulborn, Quantitative sodium MR imaging: A review of its evolving role in medicine. NeuroImage. 2018, 168: 250-268.

4. Asa SL, Mete O, Perry A, Osamura RY. Overview of the 2022 WHO Classification of Pituitary Tumors. Endocr Pathol. 2022, 33(1):6-26.

Cite this abstract

http://echo.ismrm.org/p/ISMRM2026/563-06-003